Systems analysis of GLP-1 receptor signaling in pancreatic β-cells

American Journal of Physiology - Cell Physiology

Volumn 301, Issue 4, 2011, Pages

  Takeda, Yukari ^a   Amano, Akira ^b   Noma, Akinori ^b   Nakamura, Yasuhiko ^a   Fujimoto, Shimpei ^a   Inagaki, Nobuya ^a  

^a KYOTO UNIVERSITY   (Japan)

^b RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

Adenylyl cyclase; Glucagon like peptide 1; Model stimulation; Phosphodiesterase

Indexed keywords

ADENYLATE CYCLASE; CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INTEGRASE; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; INSULINOMA; MATHEMATICAL MODEL; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE METABOLISM; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYSTEM ANALYSIS; TUMOR CELL LINE; UPREGULATION;

ANIMALS; COMPUTATIONAL BIOLOGY; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION; SYSTEMS ANALYSIS;

EID: 80053180108     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00057.2011     Document Type: Article

References (71)

1. Ahmad M, Abdel-Wahab YH, Tate R, Flatt PR, Pyne NJ, Furman BL. Effect of type-selective inhibitors on cyclic nucleotide phosphodiesterase activity and insulin secretion in the clonal insulin secreting cell line BRIN-BD11. Br J Pharmacol 129: 1228-1234, 2000.
2. Arava Y, Adamsky K, Ezerzer C, Ablamunits V, Walker MD. Specific gene expression in pancreatic beta-cells: cloning and characterization of differentially expressed genes. Diabetes 48: 552-556, 1999.
3. Baggio LL, Kim JG, Drucker DJ. Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R-dependent glucose homeostasis in vivo. Diabetes 53, Suppl 3: S205-S214, 2004
4. Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58: 488-520, 2006
5. 2+ studied in reconstituted receptor-Gs vesicles. J Biol Chem 261: 1656-1664, 1986.
6. Chen C, Nakamura T, Koutalos Y. Cyclic AMP diffusion coefficient in frog olfactory cilia. Biophys J 76: 2861-2867, 1999.
7. Christensen AE, Selheim F, de RJ, Dremier S, Schwede F, Dao KK, Martinez A, Maenhaut C, Bos JL, Genieser HG, Doskeland SO. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J Biol Chem 278: 35394-35402, 2003.
8. Cooper DM. Regulation and organization of adenylyl cyclases and cAMP. Biochem J 375: 517-529, 2003.
9. Dao KK, Teigen K, Kopperud R, Hodneland E, Schwede F, Christensen AE, Martinez A, Doskeland SO. Epac1 and cAMP-dependent protein kinase holoenzyme have similar cAMP affinity, but their cAMP domains have distinct structural features and cyclic nucleotide recognition. J Biol Chem 281: 21500-21511, 2006.
10. Dean PM. Ultrastructural morphometry of the pancreatic cell. Diabetologia 9: 115-119, 1973.
11. Delmeire D, Flamez D, Hinke SA, Cali JJ, Pipeleers D, Schuit F. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/ generator for glucose and GLP-1. Diabetologia 46: 1383-1393, 2003.
12. Dessauer CW. Adenylyl cyclase-A-kinase anchoring protein complexes: the next dimension in cAMP signaling. Mol Pharmacol 76: 935-941, 2009.
13. Dessauer CW, Scully TT, Gilman AG. Interactions of forskolin and ATP with the cytosolic domains of mammalian adenylyl cyclase. J Biol Chem 272: 22272-22277, 1997.
14. Dostmann WR, Taylor SS. Identifying the molecular switches that determine whether (Rp)-cAMPS functions as an antagonist or an agonist in the activation of cAMP-dependent protein kinase I. Biochemistry 30: 8710-8716, 1991.
15. Dov A, Abramovitch E, Warwar N, Nesher R. Diminished phosphodiesterase- 8B potentiates biphasic insulin response to glucose. Endocrinology 149: 741-748, 2008.
16. Drucker DJ. The biology of incretin hormones. Cell Metab 3: 153-165, 2006.
17. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF. Glucagonlike peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci USA 84: 3434-3438, 1987.
18. 2+ oscillations in glucose-stimulated pancreatic β-cells. Am J Physiol Endocrinol Metab 276: E512-E518, 1999.
19. Dyachok O, Isakov Y, Sagetorp J, Tengholm A. Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells. Nature 439: 349-352, 2006.
20. Enserink JM, Christensen AE, de RJ, van TM, Schwede F, Genieser HG, Doskeland SO, Blank JL, Bos JL. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 4: 901-906, 2002.
21. 2+ entry sites. J Biol Chem 271: 12438-12444, 1996.
22. Frace AM, Mery PF, Fischmeister R, Hartzell HC. Rate-limiting steps in the beta-adrenergic stimulation of cardiac calcium current. J Gen Physiol 101: 337-353, 1993.
23. 2+ and G protein-coupled receptors in the pancreatic β-cell: a computational approach. Am J Physiol Cell Physiol 293: C1924-C1933, 2007.
24. 2+ flux in pancreatic β-cells: role of the plasma membrane and intracellular stores. Am J Physiol Endocrinol Metab 285: E138-E154, 2003.
25. Gilon P, Ravier MA, Jonas JC, Henquin JC. Control mechanisms of the oscillations of insulin secretion in vitro and in vivo. Diabetes 51, Suppl 1: S144-S151, 2002.
26. Gromada J, Bokvist K, Ding WG, Holst JJ, Nielsen JH, Rorsman P. Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes 47: 57-65, 1998.
27. Gromada J, Brock B, Schmitz O, Rorsman P. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential. Basic Clin Pharmacol Toxicol 95: 252-262, 2004.
28. Han P, Werber J, Surana M, Fleischer N, Michaeli T. The calcium/ calmodulin-dependent phosphodiesterase PDE1C down-regulates glucose- induced insulin secretion. J Biol Chem 274: 22337-22344, 1999.
29. Hanoune J, Defer N. Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol 41: 145-174, 2001.
30. Harvey, RD. How uniform is cAMP signaling? Focus on "Systems analysis of GLP-1 receptor signaling in pancretic β -cells." Am J Physiol Cell Physiol (July 20, 2011). doi:10.1152./ajpcell.00245.2011.
31. Holz GG. Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes 53: 5-13, 2004.
32. Holz GG, Kuhtreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361: 362-365, 1993.
33. + current in the molluscan neuron. A diffusion-reaction model. J Gen Physiol 98: 835-848, 1991.
34. Idevall-Hagren O, Barg S, Gylfe E, Tengholm A. cAMP mediators of pulsatile insulin secretion from glucose-stimulated single beta-cells. J Biol Chem 285: 23007-23018, 2010.
35. Jorgensen R, Martini L, Schwartz TW, Elling CE. Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype. Mol Endocrinol 19: 812-823, 2005.
36. Kang G, Chepurny OG, Malester B, Rindler MJ, Rehmann H, Bos JL, Schwede F, Coetzee WA, Holz GG. cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells. J Physiol 573: 595-609, 2006.
37. 2+ release in mouse pancreatic beta cells. J Physiol 566: 173-188, 2005.
38. Kashima Y, Miki T, Shibasaki T, Ozaki N, Miyazaki M, Yano H, Seino S. Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem 276: 46046-46053, 2001.
39. 2+ and cAMP signaling in the insulin-secreting MIN6 beta-cell line. J Biol Chem 280: 31294-31302, 2005.
40. Lester LB, Langeberg LK, Scott JD. Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. Proc Natl Acad Sci USA 94: 14942-14947, 1997.
41. Li Y, Asuri S, Rebhun JF, Castro AF, Paranavitana NC, Quilliam LA. The RAP1 guanine nucleotide exchange factor Epac2 couples cyclic AMP and Ras signals at the plasma membrane. J Biol Chem 281: 2506-2514, 2006.
42. Light PE, Manning Fox JE, Riedel MJ, Wheeler MB. Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism. Mol Endocrinol 16: 2135-2144, 2002.
43. MacDonald PE, Salapatek AM, Wheeler MB. Glucagon-like peptide-1 receptor activation antagonizes voltage-dependent repolarizing K(+) currents in beta-cells: a possible glucose-dependent insulinotropic mechanism. Diabetes 51, Suppl 3: S443-S447, 2002.
44. Mathi SK, Chan Y, Li X, Wheeler MB. Scanning of the glucagon-like peptide-1 receptor localizes G protein-activating determinants primarily to the N terminus of the third intracellular loop. Mol Endocrinol 11: 424-432, 1997.
45. Meyer-Hermann ME. The electrophysiology of the beta-cell based on single transmembrane protein characteristics. Biophys J 93: 2952-2968, 2007.
46. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91: 301-307, 1993.
47. Nijholt IM, Dolga AM, Ostroveanu A, Luiten PG, Schmidt M, Eisel UL. Neuronal AKAP150 coordinates PKA and Epac-mediated PKB/Akt phosphorylation. Cell Signal 20: 1715-1724, 2008.
48. Oliveira RF, Terrin A, Di BG, Cannon RC, Koh W, Kim M, Zaccolo M, Blackwell KT. The role of type 4 phosphodiesterases in generating microdomains of cAMP: large scale stochastic simulations. PLoS One 5: e11725, 2010.
49. Pipeleers D. The biosociology of pancreatic B cells. Diabetologia 30: 277-291, 1987.
50. Ponsioen B, Gloerich M, Ritsma L, Rehmann H, Bos JL, Jalink K. Direct spatial control of Epac1 by cyclic AMP. Mol Cell Biol 29: 2521-2531, 2009.
51. Post SR, Hilal-Dandan R, Urasawa K, Brunton LL, Insel PA. Quantification of signalling components and amplification in the beta-adrenergic- receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes. Biochem J 311: 75-80, 1995.
52. Pyne NJ, Furman BL. Cyclic nucleotide phosphodiesterases in pancreatic islets. Diabetologia 46: 1179-1189, 2003.
53. Rehmann H, Arias-Palomo E, Hadders MA, Schwede F, Llorca O, Bos JL. Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B. Nature 455: 124-127, 2008.
54. Roger B, Papin J, Vacher P, Raoux M, Mulot A, Dubois M, Kerr- Conte J, Voy BH, Pattou F, Charpentier G, Jonas JC, Moustaid- Moussa N, Lang J. Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells. Diabetologia 54: 390-402, 2011.
55. Sams DJ, Montague W. The role of adenosine 3=:5=-cyclic monophosphate in the regulation of insulin release. Properties of islet-cell adenosine 3=:5=-cyclic monophosphate phosphodiesterase. Biochem J 129: 945-952, 1972.
56. 2+]i oscillations due to bursting electrical activity in single pancreatic islets. Pflügers Arch 418: 417-422, 1991.
57. Saucerman JJ, Brunton LL, Michailova AP, McCulloch AD. Modeling beta-adrenergic control of cardiac myocyte contractility in silico. J Biol Chem 278: 47997-48003, 2003.
58. 2+ channels of pancreatic B-cells through c-AMP signaling. Jpn J Physiol 47, Suppl 1: S13-S14, 1997.
59. Sunahara RK, Dessauer CW, Whisnant RE, Kleuss C, Gilman AG. Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase. J Biol Chem 272: 22265-22271, 1997.
60. Syme CA, Zhang L, Bisello A. Caveolin-1 regulates cellular trafficking and function of the glucagon-like Peptide 1 receptor. Mol Endocrinol 20: 3400-3411, 2006.
61. Tengholm A, Gylfe E. Oscillatory control of insulin secretion. Mol Cell Endocrinol 297: 58-72, 2009.
62. Terrin A, Di BG, Pertegato V, Cheung YF, Baillie G, Lynch MJ, Elvassore N, Prinz A, Herberg FW, Houslay MD, Zaccolo M. PGE(1) stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases. J Cell Biol 175: 441-451, 2006.
63. Thorens B. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89: 8641-8645, 1992.
64. Tsalkova T, Blumenthal DK, Mei FC, White MA, Cheng X. Mechanism of Epac activation: structural and functional analyses of Epac2 hinge mutants with constitutive and reduced activities. J Biol Chem 284: 23644-23651, 2009.
65. 2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells. Biochem J 369: 287-299, 2003.
66. Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, Boyd AE, III. Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Endocrinology 133: 57-62, 1993.
67. Widmann C, Burki E, Dolci W, Thorens B. Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines. Mol Pharmacol 45: 1029-1035, 1994.
68. Widmann C, Dolci W, Thorens B. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate. Mol Endocrinol 10: 62-75, 1996.
69. Yan C, Zhao AZ, Bentley JK, Beavo JA. The calmodulin-dependent phosphodiesterase gene PDE1C encodes several functionally different splice variants in a tissue-specific manner. J Biol Chem 271: 25699-25706, 1996.
70. Yu X, Byrne JH, Baxter DA. Modeling interactions between electrical activity and second-messenger cascades in Aplysia neuron R15. J Neurophysiol 91: 2297-2311, 2004.
71. Zaccolo M, Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295: 1711-1715, 2002.